BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15968833)

  • 1. New aspects in the classification of carcinogens.
    Foth H; Degen GH; Bolt HM
    Arh Hig Rada Toksikol; 2005 Jun; 56(2):167-75. PubMed ID: 15968833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
    Hengstler JG; Bogdanffy MS; Bolt HM; Oesch F
    Annu Rev Pharmacol Toxicol; 2003; 43():485-520. PubMed ID: 12415124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action-based risk assessment of genotoxic carcinogens.
    Hartwig A; Arand M; Epe B; Guth S; Jahnke G; Lampen A; Martus HJ; Monien B; Rietjens IMCM; Schmitz-Spanke S; Schriever-Schwemmer G; Steinberg P; Eisenbrand G
    Arch Toxicol; 2020 Jun; 94(6):1787-1877. PubMed ID: 32542409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants.
    Rosenkranz HS; Klopman G
    Mutat Res; 1990 Feb; 228(2):105-24. PubMed ID: 2300064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.
    Melis JP; Derks KW; Pronk TE; Wackers P; Schaap MM; Zwart E; van Ijcken WF; Jonker MJ; Breit TM; Pothof J; van Steeg H; Luijten M
    Arch Toxicol; 2014 Apr; 88(4):1023-34. PubMed ID: 24390151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests.
    Kirkland D; Kasper P; Martus HJ; Müller L; van Benthem J; Madia F; Corvi R
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Jan; 795():7-30. PubMed ID: 26774663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity--threshold or not? Introduction of cases of industrial chemicals.
    Bolt HM
    Toxicol Lett; 2003 Apr; 140-141():43-51. PubMed ID: 12676450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relation between carcinogenesis and mutagenesis: a re-evaluation].
    Bartsch H; Malaveille C
    Bull Acad Natl Med; 1989 Nov; 173(8):1005-12; discussion 1013-5. PubMed ID: 2633853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategy of the scientific committee on occupational exposure limits (SCOEL) in the derivation of occupational exposure limits for carcinogens and mutagens.
    Bolt HM; Huici-Montagud A
    Arch Toxicol; 2008 Jan; 82(1):61-4. PubMed ID: 18008062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed changes in the classification of carcinogenic chemicals in the work area.
    Neumann HG; Thielmann HW; Filser JG; Gelbke HP; Greim H; Kappus H; Norpoth KH; Reuter U; Vamvakas S; Wardenbach P; Wichmann HE
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):288-95. PubMed ID: 9441919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative DNA damage and in vivo mutagenicity caused by reactive oxygen species generated in the livers of p53-proficient or -deficient gpt delta mice treated with non-genotoxic hepatocarcinogens.
    Tasaki M; Kuroiwa Y; Inoue T; Hibi D; Matsushita K; Ishii Y; Maruyama S; Nohmi T; Nishikawa A; Umemura T
    J Appl Toxicol; 2013 Dec; 33(12):1433-41. PubMed ID: 22972318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.